Fractyl Health GUTS
NASDAQ GUTS
$0.78 +0.09 (+13.85%)
At close: Aug 21, 2026 · 4:00 PM EDT

Fractyl Health (GUTS) Other Accumulated Expenses (2023 - 2026)

Fractyl Health's (GUTS) quarterly Other Accumulated Expenses came in at $596000.0 in Q1 2026, down 92.54% YoY from $8.0 million in Q1 2025, and down 37.98% on a QoQ basis from $961000.0 in Q4 2025.

Fractyl Health (GUTS) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

Fractyl Health (GUTS) has 4 years of Other Accumulated Expenses data on file, last reported at $596000.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 92.54% year-over-year to $596000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $596000.0 (down 92.54% YoY) and the FY2025 annual result came in at $961000.0, up 15.64% from the prior year.
  • Other Accumulated Expenses fell to $596000.0 in Q1 2026, from $961000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $8.4 million in Q2 2025 to a low of $2000.0 in Q4 2023.
  • A 4-year average of $2.6 million and a median of $713500.0 in 2024 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 41450.0% — and 2026, when it sank 92.54%.
  • Tracing GUTS's Other Accumulated Expenses over 4 years: stood at $2000.0 in 2023, then soared by 41450.0% to $831000.0 in 2024, then climbed by 15.64% to $961000.0 in 2025, then slumped by 37.98% to $596000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $596000.0 (Q1 2026), $961000.0 (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Fractyl Health 123.81 Mn 123.81 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 755,000.00
Mar 31, 2026 596,000.00
Dec 31, 2025 961,000.00
Sep 30, 2025 5.92 Mn
Jun 30, 2025 8.41 Mn
Mar 31, 2025 7.99 Mn
Dec 31, 2024 831,000.00
Sep 30, 2024 445,000.00
Jun 30, 2024 427,000.00
Mar 31, 2024 99,000.00
Dec 31, 2023 2,000.00